Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200039/S022

Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter; Sh

Shockwave Medical, Inc. · Decision date May 7, 2026

FDA DECISIONP200039/S022

What did the FDA decide?

FDA records P200039/S022 as a supplement to PMA P200039, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 7, 2026.

FDA approval order statement

a change to the Shockwave C2/C2+ Coronary IVL Catheters coated balloon subassembly in-process inspection acceptance criteria for cumulative coating voids at the supplier
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
May 7, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P200039/S022
Regulatory pathway
PMA supplement
Product code
QMG
Decision code
OK30
Decision date
May 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Shockwave intravascular lithotripsy system.

Product code
QMG
FDA device class
3

For the original device and its historical approval scope, see PMA P200039. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200039 · Original PMA

    Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter

  2. P200039/S018 · Related supplement

    Shockwave lntravascular Lithotripsy {IVL) System with Shockwave C2/ C2+/ C2 Aero Coronary IVL Catheter

  3. P200039/S019 · Related supplement

    Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Aero Fly Coronary Intravascular Lithotripsy (IVL) Cat

  4. P200039/S020 · Related supplement

    Shockwave lntravascular Lithotripsy (IVL) System with Shockwave C2 Aero Coronary IVL Catheter

  5. P200039/S022 received

    Application receipt date recorded by FDA.

  6. P200039/S022 · FDA decision

    30-Day Notice

  7. P200039/S021 · Related supplement

    Shockwave lntravascular Lithotripsy (IVL) System with Shockwave C2 / C2+ / C2 Aero/ C2 Aero Fly Coronary IVL Catheter

  8. P200039/S023 · Related supplement

    Shockwave lntravascular Lithotripsy (IVL) System with Shockwave C2 Aero Fly Coronary IVL Catheter

  9. P200039/S025 · Related supplement

    SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH SHOCKWAVE C2/C2+ CORONARY IVL CATHETER

Timeline entries are records held by MedtechLedger for P200039. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200039

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shockwave Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
5403 Betsy Ross Dr., Santa Clara, CA, 95054

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records